MTP Kit

The MTP Kit is FDA Approved combination of medicines Mifepristone (200 mg) + Misoprostol (200 mcg each) for terminating early pregnancy safely, effective within 63 days of gestation. This timeline is calculated from the last menstrual period, considering ovulation around 14 days into a typical 28-day cycle. Prior to treatment, any intrauterine device (IUD) must be removed, as it can interfere with the process. After administering Mifepristone, Misoprostol should be taken 1-3 days later for optimal efficacy. It’s crucial to follow dosage instructions carefully and consult a healthcare provider for any concerns.

Recommended Doses of MTP Kit

The recommended dosage includes one tablet of Mifepristone (200 mg) taken orally, followed by four tablets of Misoprostol (200 mcg each) administered either orally or vaginally after 24-72 hours. The mode of administration depends on patient preference and bleeding patterns.

Potential Side Effects of MTP Kit

Users of the MTP Kit may experience side effects such as heavy bleeding lasting more than 2-3 hours, dizziness, nausea, vomiting, fever, and diarrhea. In some cases, excessive bleeding may indicate retained tissue, requiring immediate medical consultation. Additional symptoms may include abdominal pain, urinary tract infections, and general fatigue. It is essential to monitor for prolonged or severe side effects and seek medical advice promptly.

Precautions While Using MTP Kit

The MTP Kit (Mifepristone + Misoprostol) should only be used by individuals prescribed this medication. Prior to use, any intrauterine device must be removed. This kit is not suitable for ectopic pregnancies. Due to potential dizziness, activities requiring alertness, such as driving or operating machinery, should be avoided. Patients with pre-existing conditions like diabetes, hypertension, or liver issues must consult their healthcare provider before use. Smoking and alcohol consumption should also be avoided during treatment.